SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bayhill Therapeutics, Inc. Enters Exclusive, Worldwide Collaboration with Genentech, Inc. (JOBS) for BHT-3021 in Type 1 Diabetes; Deal Could Potentially Exceed $350M